Brain disorder mechanisms and therapeutic targets identified from developmental, cell-specific gene regulation

Genetic variation influences brain physiology and disease across cell types and development. We integrated whole-genome sequencing, bulk RNA sequencing, and single-nucleus multiome profiling from 231 human dorsolateral prefrontal cortex donors spanning six postconceptional weeks to 92 years. Across 24 brain-related traits, neurodevelopmental and psychiatric genetic risk was enriched in neuronal transcriptomic and chromatin profiles, whereas neurodegenerative risk was enriched in microglia. Thousands of expression, chromatin accessibility, and splicing quantitative trait loci revealed developmental and cell-type-specific regulatory effects. Colocalization linked multiple sclerosis risk to AHI1 expression in prenatal neurons and problematic alcohol use to GPX1 expression in postnatal glia. Leveraging dynamic cis-regulatory elements, we identified therapeutic candidates for haploinsufficient neurodevelopmental disorders, including a SOX5 enhancer whose CRISPR activation increased transcript and protein abundance. Together, these findings establish a publicly accessible genomic resource for resolving the developmental and cellular contexts of genetic risk and identifying therapeutic targets in the human brain.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-11-17
DOI
https://doi.org/10.64898/2026.11.15.766341
Primary Topic
Genomics and Chromatin Dynamics
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Brain disorder mechanisms and therapeutic targets identified from developmental, cell-specific gene regulation

Harrison Brand, Jakob Weiß, Matthew J. Girgenti, Chun Jimmie Ye et al.
3 links
bioRxiv (Cold Spring Harbor Laboratory)
Genomics and Chromatin Dynamics
preprint

Brain disorder mechanisms and therapeutic targets identified from developmental, cell-specific gene regulation

Harrison Brand, Jakob Weiß, Matthew J. Girgenti, Chun Jimmie Ye, Homa Adle‐Biassette, Theodora Markati, Shaojie Ma, Emilie M. Wigdor, Soo-Whee Kim, Bernie Devlin, Xuran Wang, Antonio Garcia-Guerra, Donna M. Werling, Nenad Šestan, Alexa‐Nicole Sliby, Rothem Kovner, Philip L. De Jager, Stephan Sanders, Narjes Rohani, Sandra Canosa, M. Grace Gordon, Sirisha Pochareddy, Michael E. Talkowski, Joseph L. Lalli, Lambertus Klei, Alicia Ljungdahl, Pooja Kathail, Hyesun Cho, Kathryn Roeder, Dan Liang, Xuefang Zhao, Shan Dong, Nicholas F. Page, Menglei Zhang, Yuting Liu, Qi Xu, Carlo Rinaldi, Ashley Deveau-French, Chimmi Dema, Karan Jaisingh, Anandita Nadkarni, Michael Griffiths, Ruhani Makkar, Joy Kachko, Mingli Li, Daniel Speckhard-Pasque, Yujin Kim
preprint en

Abstract

Genetic variation influences brain physiology and disease across cell types and development. We integrated whole-genome sequencing, bulk RNA sequencing, and single-nucleus multiome profiling from 231 human dorsolateral prefrontal cortex donors spanning six postconceptional weeks to 92 years. Across 24 brain-related traits, neurodevelopmental and psychiatric genetic risk was enriched in neuronal transcriptomic and chromatin profiles, whereas neurodegenerative risk was enriched in microglia. Thousands of expression, chromatin accessibility, and splicing quantitative trait loci revealed developmental and cell-type-specific regulatory effects. Colocalization linked multiple sclerosis risk to AHI1 expression in prenatal neurons and problematic alcohol use to GPX1 expression in postnatal glia. Leveraging dynamic cis-regulatory elements, we identified therapeutic candidates for haploinsufficient neurodevelopmental disorders, including a SOX5 enhancer whose CRISPR activation increased transcript and protein abundance. Together, these findings establish a publicly accessible genomic resource for resolving the developmental and cellular contexts of genetic risk and identifying therapeutic targets in the human brain.

bioRxiv (Cold Spring Harbor Laboratory)
Broad Institute (US), University of Minnesota (US), Pennsylvania State University (US), University of Wisconsin–Madison (US), Harvard University (US), Inserm (FR), University of Pittsburgh (US), University of California, San Francisco (US), Genentech (US), Université Paris Cité (FR), Columbia University Irving Medical Center (US), John Radcliffe Hospital (GB), Yale University (US), University of Oxford (GB), Massachusetts General Hospital (US), Assistance Publique – Hôpitaux de Paris (FR), Center for Excellence in Brain Science and Intelligence Technology (CN), Hôpital Lariboisière (FR), New York Genome Center (US), University of Chinese Academy of Sciences (CN), NeuroDiderot (FR), Stanley Center for Psychiatric Research (US), Carnegie Mellon University (US), University of San Francisco (US), Penn State Milton S. Hershey Medical Center (US), University of California, Berkeley (US), Icahn School of Medicine at Mount Sinai (US)
Good health and well-being
Genomics and Chromatin Dynamics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon